These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8938673)
1. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. Rostaing L; Modesto A; Baron E; Cisterne JM; Chabannier MH; Durand D Nephron; 1996; 74(3):512-6. PubMed ID: 8938673 [TBL] [Abstract][Full Text] [Related]
2. [Acute renal insufficiency in renal transplants treated with interferon-alpha for chronic hepatitis C]. Rostaing L; Modesto A; Baron E; Cisterne JM; Chabannier MH; Tkaczuk J; Durand D; Suc JM Nephrologie; 1996; 17(4):247-54. PubMed ID: 8768457 [TBL] [Abstract][Full Text] [Related]
3. Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients. Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D; Suc JM Nephrol Dial Transplant; 1995; 10 Suppl 6():93-6. PubMed ID: 8524507 [TBL] [Abstract][Full Text] [Related]
4. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C. Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758 [TBL] [Abstract][Full Text] [Related]
5. Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: case study. Fabrizi F; D'Ambrosio R; Pallotti F; Berardinelli L; Messa P; Martin P; Aghemo A Int J Artif Organs; 2014 Nov; 37(11):803-8. PubMed ID: 25362901 [TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D Transplantation; 1995 May; 59(10):1426-31. PubMed ID: 7770930 [TBL] [Abstract][Full Text] [Related]
7. Does elevation of serum creatinine in patients with chronic hepatitis C under therapy of telaprevir mean renal impairment? Matsui K; Kamijo-Ikemori A; Sugaya T; Ikeda H; Okuse C; Shibagaki Y; Yasuda T; Kimura K Nephrology (Carlton); 2015 Nov; 20(11):843-8. PubMed ID: 25998031 [TBL] [Abstract][Full Text] [Related]
8. Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects? Gluhovschi C; Gadalean F; Kaycsa A; Curescu M; Sporea I; Gluhovschi G; Petrica L; Velciov S; Bozdog G; Bob F; Vernic C; Cioca D Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):744-50. PubMed ID: 21320001 [TBL] [Abstract][Full Text] [Related]
9. Progressive renal failure and blindness due to retinal hemorrhage after interferon therapy for hepatitis C virus-associated membranoproliferative glomerulonephritis. Suzuki T; Yonemura K; Miyaji T; Suzuki H; Takahira R; Fujigaki Y; Fujimoto T; Hishida A Intern Med; 2001 Aug; 40(8):708-12. PubMed ID: 11518107 [TBL] [Abstract][Full Text] [Related]
10. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study. Farrell GC; Bacon BR; Goldin RD Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation. Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625 [TBL] [Abstract][Full Text] [Related]
12. Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis. Markowitz GS; Nasr SH; Stokes MB; D'Agati VD Clin J Am Soc Nephrol; 2010 Apr; 5(4):607-15. PubMed ID: 20203164 [TBL] [Abstract][Full Text] [Related]
13. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients]. Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722 [TBL] [Abstract][Full Text] [Related]
14. Acute tubular necrosis following interferon-based therapy for hepatitis C: case study with literature review. Fabrizi F; Aghemo A; Fogazzi GB; Moroni G; Passerini P; D'Ambrosio R; Messa P Kidney Blood Press Res; 2013; 38(1):52-60. PubMed ID: 24556714 [TBL] [Abstract][Full Text] [Related]
15. Reversible renal failure in a patient with the hypereosinophilia syndrome during therapy with alpha interferon. Nassar GM; Pedro P; Remmers RE; Mohanty LB; Smith W Am J Kidney Dis; 1998 Jan; 31(1):121-6. PubMed ID: 9428462 [TBL] [Abstract][Full Text] [Related]
16. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C. Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Reed A; Hemming A; Howard R; Van Der Werf W; Lauwers G; Liu C; Crawford JM; Davis GL; Nelson DR Liver Transpl; 2002 Nov; 8(11):1000-6. PubMed ID: 12424712 [TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715 [TBL] [Abstract][Full Text] [Related]
18. Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C. Huraib S; Iqbal A; Tanimu D; Abdullah A Am J Nephrol; 2001; 21(6):435-40. PubMed ID: 11799259 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of hepatitis B vaccination and interferon-alpha-2b combination therapy versus interferon-alpha-2b monotherapy in children with chronic hepatitis B. Helvaci M; Kizilgunesler A; Kasirga E; Ozbal E; Kuzu M; Sozen G J Gastroenterol Hepatol; 2004 Jul; 19(7):785-91. PubMed ID: 15209626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]